AZN registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Completion date | Oct 31, 2031 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Primary completion date | Oct 31, 2031 (sponsor estimate) | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | Sep 5, 2023 (actual) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Primary completion date | May 17, 2022 (actual) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Results posted | Results posted to the registry | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Jun 30, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Mar 31, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Sep 3, 2026 (actual) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Aug 19, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Aug 19, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Feb 22, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Mar 17, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Mar 17, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Oct 20, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Primary completion date | Oct 20, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Oct 20, 2026 (actual) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Oct 20, 2026 (actual) | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETCompletion dateNCT07882212GRACE-DE: Prospective Multicenter Real-world Gastric Cancer Patients Starting AZ-developed and Approved Drugs in Germany (Umbrella Study)AZN
- Now
- Oct 31, 2031 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETPrimary completion dateNCT07882212GRACE-DE: Prospective Multicenter Real-world Gastric Cancer Patients Starting AZ-developed and Approved Drugs in Germany (Umbrella Study)AZN
- Now
- Oct 31, 2031 (sponsor estimate)
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT07882212GRACE-DE: Prospective Multicenter Real-world Gastric Cancer Patients Starting AZ-developed and Approved Drugs in Germany (Umbrella Study)AZN
- Now
- Recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion dateNCT03699449An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)AZN
- Now
- Sep 5, 2023 (actual)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETPrimary completion dateNCT03699449An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)AZN
- Now
- May 17, 2022 (actual)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT03699449An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)AZN
- Now
- Completed
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT06307652Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionAZN
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETResults postedNCT03534453Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyAZN
- Now
- Results posted to the registry
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion dateNCT03768570Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder CancerAZN
- Now
- Jun 30, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT03768570Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder CancerAZN
- Now
- Mar 31, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion date
- Now
- Sep 3, 2026 (actual)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion date
- Now
- Aug 19, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion date
- Now
- Aug 19, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion dateNCT06834932A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With DyslipidaemiaAZN
- Now
- Feb 22, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatusNCT06218914Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsAZN
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion dateNCT07812077A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD4954 and the Absolute Bioavailability...AZN
- Now
- Mar 17, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion dateNCT07812077A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD4954 and the Absolute Bioavailability...AZN
- Now
- Mar 17, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatusNCT07812077A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD4954 and the Absolute Bioavailability...AZN
- Now
- Recruiting
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion date
- Now
- Oct 20, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETPrimary completion date
- Now
- Oct 20, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT06566885Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in RussiaAZN
- Now
- Oct 20, 2026 (actual)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion dateNCT06566885Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in RussiaAZN
- Now
- Oct 20, 2026 (actual)
- Before
- Locked
The previous value and the sponsor's record update date are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 changes. There are 6 more in this window; the full list is part of TrialScanner.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.